Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

Stopped A number of subjects withdrew consent leaving the study without adequate power to achieve its primary end points.

Conditions

• Drug-Interactions

Interventions

• DRUG: ecopipam HCl ~2mg/kg/day
• COMBINATION_PRODUCT: Cohort 1 Probe Cocktail
• COMBINATION_PRODUCT: Cohort 2 Probe Cocktail
• COMBINATION_PRODUCT: Cohort 3 Probe Cocktail

Sponsor

Emalex Biosciences Inc.

Collaborators

• [object Object]
• [object Object]